Dr. Kesari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Saint John's Cancer Institute at Providence Saint John’s Health Center
2200 Santa Monica Blvd.
Santa Monica, CA 90404Phone+1 310-829-8265Fax+1 310-582-7287
Summary
- Dr. Santosh Kesari is a board-certified neurologist and neuro-oncologist and is currently Chair, Department of Neurosciences and Neurotherapeutics, John Wayne Cancer Institute and Pacific Neuroscience Institute. He is also Director of Neuro-Oncology, Providence Saint John’s Health Center and Member, Los Angeles Biomedical Research Institute. Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and an internationally recognized scientist and clinician. He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books. He is the inventor on several patents and patent applications, and founder and advisor to many cancer and neurosciences focused biotech startups.
Dr. Kesari graduated from University of Pennsylvania, School of Arts and Sciences in 1992 and earned a Ph.D. degree in molecular biology and a M.D. from the University of Pennsylvania, School of Medicine. He completed his residency in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston. He was previously assistant professor of neurology at Harvard Medical School/Dana-Farber Cancer Institute/Brigham and Women’s Hospital and then professor of neurosciences at UC San Diego. He is a member of the Society of Neuro-Oncology, American Society of Clinical Oncology, Indian Society of Neuro-Oncology, American Neurological Association, and American Academy of Neurology. For information about Dr. Kesari's research, go to http://www.pacificneuroscienceinstitute.org/people/santosh-kesari-md-phd/.
Education & Training
- Dana-Farber Cancer InstituteFellowship, Cancer Biology, 2004 - 2006
- Massachusetts Gen Hosp2003 - 2006
- Dana-Farber Cancer Institute/BWH/MGH2003 - 2004
- Harvard School of Public HealthProgram, Clinical Effectiveness, 2004
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2000 - 2003
- Harvard Medical School2000 - 2003
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolInternship, Neurology, 1999 - 2000
- Brigham and Women's HospitalFellowship, Internal Medicine, 1999 - 2000
- Perelman School of Medicine at the University of PennsylvaniaClass of 1999, MD
- National Hospital for Neurology and NeurosurgeryExtern, 1999
- University of Pennsylvania School of MedicinePh.D, Molecular Biology, 1993 - 1996
- University of Pennsylvania, College of Arts and SciencesBA, Biology and Mathematics, 1989
- George Washington High SchoolHS, 1989
Certifications & Licensure
- CA State Medical License 2009 - 2025
- MA State Medical License 2001 - 2010
- National Board of Physicians and Surgeons Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Join now to see all
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 95 citationsEfficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.Claire M. Sauvageot, Jessica Weatherbee, Santosh Kesari, Susan Elizabeth Winters, Jessica W. Barnes
Neuro-Oncology. 2009-04-01 - 163 citationsUnleashing endogenous TNF-alpha as a cancer immunotherapeutic.Steven F. Josephs, Thomas E. Ichim, Prince Stephen Michael, Santosh Kesari, Francesco M. Marincola
Journal of Translational Medicine. 2018-08-31 - 169 citationsAssociation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01
Journal Articles
- Fibroblasts as a Practical Alternative to Mesenchymal Stem CellsSantosh Kesari, MD, BioMed Central
- Pritumumab, the First Therapeutic Antibody for Glioma PatientsSantosh Kesari, MD, Journal of Pediatric Rehabilitation Medicine
- Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant.Randazzo BP, Kesari S, Gesser RM, Alsop D, Ford JC, Brown SM, MacLean AR, Fraser NW, Virology; 211(1):94-101
- Join now to see all
Books/Book Chapters
Lectures
- Advances in the Management of Recurrent Glioblastoma.Lehigh Valley Hospital, Allentown, Pennsylvania
- Progress in Neuro-Oncology.Oregon Health & Science University, Portland, Oregon
- Clinical and Molecular Heterogeneity in Brain Cancers.Arizona State University, Phoenix, Arizona
- Join now to see all
Other
- Systems and Methods for Internal Organ Mico-imaging in situ using scanning fiber-optic microscopes.Santosh Kesari, BWH
- Small Molecule Microarrays and Methods for Making and Using them.Shu Chein, Dayu Teng, Santosh Kesari, Pengfei Jiang, UCSD SD2011-024 (provisional patent 61/375,373, filed 8/20/10)
- Diagnosing CNS Malignancies Using MicroRNA.Anna M. Krichevsky, Brit Mollenhauer, Nadiya M Teplyuk, Santosh Kesari
- Join now to see all
Press Mentions
- ALS Treatment: FDA to Rule on Drug Tofersen for Specific Type of the DiseaseApril 19th, 2023
- Alzheimer's Disease: Modified mRNA Helps Reduce Symptoms in Mouse ModelMarch 14th, 2023
- Why Some Cancer Tumors Can Become Resistant to ChemotherapyMarch 8th, 2023
- Join now to see all
Other Languages
- Telugu
External Links
- PNIhttp://www.pacificneuroscienceinstitute.org/people/santosh-kesari-md-phd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: